Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) shares are popping Thursday following an update on its Juxtapid drug.

According to slides ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE